It is noteworthy that some FCAS/MWS/CINCA patients carry NLRP3 mosaic variants in a subgroup of leukocytes, making molecular diagnosis difficult unless those variants are specifically sought by next generation sequencing (NGS) analysis. This evidence concerns the gene NLRP3 and CINCA syndrome.